| Document Date: 2009-02-06 08:51:47
Open Document File Size: 92,25 KBShare Result on Facebook
Company AstraZeneca Plc / ratiopharm GmbH / AstraZeneca AB / Hässle AB / Astra AB / / Continent Europe / / Country Germany / Norway / Belgium / Netherlands / United Kingdom / Sweden / Denmark / / Currency EUR / / Event Product Issues / Patent Filing / Product Recall / / IndustryTerm anti-ulcer products / pharmaceutical product / pharmaceutical history / pharmaceutical sector / pharmaceutical market / i.e. national health systems / competition law / health systems / pharmaceutical legislation / pharmaceutical products / pharmaceutical / generic products / medicinal products / pharmaceutical prescription markets / anti-ulcer product / / Position counsel / legislator / Directorate-General / / Product Losec capsules / Losec tablets / Losec MUPS tablets / / ProgrammingLanguage EC / / ProvinceOrState Arizona / /
SocialTag |
Antitrust AstraZeneca: the first abuse case in the pharmaceutical sector Niklas FAGERLUND and Søren Bo RASMUSSEN, Directorate-General Competition, unit B-2 1. Introduction